Health
Pfizer SARS-CoV-2 vaccine effective from day 11 post 1st vaccination – News-Medical.Net
New research from a team of scientists in Australia finds that the second ‘booster’ dose of the Pfizer-BioNTech vaccine did not increase vaccine efficacy against…
New research from a team of scientists in Australia suggests that the second ‘booster’ dose of the Pfizer-BioNTech vaccine may not increase vaccine efficacy against severe acute respiratory syndrome (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19).
The results suggest one dose of the vaccine could be sufficient in providing a robust immune response 11 days after inoculation.
The findings could help shape policy as vaccine rollout has been slow in countries such as the United…
-
Business15 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business19 hours agoThis leading broker thinks the CSL share price can climb 40%
-
Business12 hours agoDicker Data rides the AI trend to double digit growth
-
Noosa News19 hours agoOld Translink app canned, and new version ‘worse than paper map from 2015’